Literature DB >> 15327795

Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.

Silvia M Estein1, Pablo C Cheves, María A Fiorentino, Juliana Cassataro, Fernando A Paolicchi, Raúl A Bowden.   

Abstract

Detergent-extracted recombinant Omp31 (rOmp31 extract) from Brucella melitensis produced in Escherichia coli was previously identified as a protective immunogen against B. ovis in mice. In this study, we evaluated the immunogenicity of rOmp31extract in rams. This immunogen was emulsified in an oil adjuvant and administered three times with 4 and 8 weeks intervals. Antibody response was measured in serum by whole B. ovis ELISA. Specific antibodies to purified rOmp31 (pET-Omp31) were detected by Western blotting and indirect ELISA. In addition, isotype specific antibodies were measured in tears. Serum bactericidal activity against B. ovis in the presence of complement was measured in vitro. Cellular immune response was explored by intradermal testing with purified rOmp31. Immunization with rOmp31 extract induced IgG specific antibodies in serum able to bind to whole B. ovis cells. Furthermore, strong inhibition in a competitive ELISA (with an Omp31-specific monoclonal antibody) suggested that a proportion of Omp31-specific antibodies were directed against a loop containing a protective epitope. Serum antibodies killed efficiently B. ovis in vitro in the presence of either guinea pig or ovine serum. Tears had both IgG and IgA antibodies to equivalent titers. Finally, immunized rams showed skin reactivity to Omp31. These data demonstrate that B. melitensis Omp31, a protective antigen identified in the mouse model, induces antibody and cellular immune mechanisms in sheep.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327795     DOI: 10.1016/j.vetmic.2004.05.004

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  10 in total

1.  Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.

Authors:  Juliana Cassataro; Silvia M Estein; Karina A Pasquevich; Carlos A Velikovsky; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Construction of an expression plasmid (vector) encoding Brucella melitensis outer membrane protein, a candidate for DNA vaccine.

Authors:  Fatemeh Vahedi; Elnaz Ghorbani; Tahereh Falsafi
Journal:  Rep Biochem Mol Biol       Date:  2013-04

3.  Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.

Authors:  Maria Clausse; Alejandra G Díaz; Andrés E Ibañez; Juliana Cassataro; Guillermo H Giambartolomei; Silvia M Estein
Journal:  Clin Vaccine Immunol       Date:  2014-10-22

4.  Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.

Authors:  Cora N Pollak; María Magdalena Wanke; Silvia M Estein; M Victoria Delpino; Norma E Monachesi; Elida A Comercio; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

5.  Role of the Omp25/Omp31 family in outer membrane properties and virulence of Brucella ovis.

Authors:  Paola Caro-Hernández; Luis Fernández-Lago; María-Jesús de Miguel; Ana I Martín-Martín; Axel Cloeckaert; María-Jesús Grilló; Nieves Vizcaíno
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

6.  16S rRNA and omp31 gene based molecular characterization of field strains of B. melitensis from aborted foetus of goats in India.

Authors:  Ajay Singh; Vivek Kumar Gupta; Amit Kumar; Vikas Kumar Singh; Shivasharanappa Nayakwadi
Journal:  ScientificWorldJournal       Date:  2013-12-18

7.  An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.

Authors:  Meng-Hooi Shu; NorAziyah MatRahim; NurAsyura NorAmdan; Sui-Ping Pang; Sharina H Hashim; Wai-Hong Phoon; Sazaly AbuBakar
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

8.  Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodies.

Authors:  Jinfeng Li; Feihuan Hu; Shouyi Chen; Peifang Luo; Zuoping He; Wenjing Wang; Jean-Pierre Allain; Chengyao Li
Journal:  BMC Microbiol       Date:  2017-05-15       Impact factor: 3.605

9.  Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing.

Authors:  Shubham Mathur; Menachem Banai; Dani Cohen
Journal:  Vaccines (Basel)       Date:  2022-02-17

10.  Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.

Authors:  Pilar Sancho; Carmen Tejedor; Rebeca S Sidhu-Muñoz; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Vet Res       Date:  2014-06-04       Impact factor: 3.683

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.